GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $27,000 | -15.6% | 615 | -14.3% | 0.01% | -12.5% |
| Q4 2021 | $32,000 | -3.0% | 718 | -16.2% | 0.01% | -20.0% |
| Q3 2021 | $33,000 | -2.9% | 857 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $34,000 | -60.0% | 857 | -64.1% | 0.01% | -60.9% |
| Q1 2021 | $85,000 | -15.0% | 2,388 | -12.7% | 0.02% | -23.3% |
| Q4 2020 | $100,000 | +4.2% | 2,734 | -2.6% | 0.03% | -3.2% |
| Q3 2020 | $96,000 | – | 2,806 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |